CVE-2026-1029: IBM Common Licensing Agent XSS Vulnerability

CVE-2026-1029 Overview

CVE-2026-1029 is a stored cross-site scripting (XSS) vulnerability in IBM Common Licensing Agent and ART versions 9.0, 9.0.0.1, and 9.0.0.2. The flaw allows an authenticated user to embed arbitrary JavaScript into the product's Web UI. When another user renders the affected page, the injected script executes in the context of the trusted session. This can alter application functionality and expose credentials or session data. The weakness is tracked under CWE-79 and requires user interaction to complete exploitation. IBM has published guidance for affected customers on the IBM Support Page.

Critical Impact
Authenticated attackers can inject JavaScript that runs in other users' browsers, enabling credential disclosure and session manipulation within the trusted Web UI.

Affected Products

IBM Common Licensing Agent 9.0, 9.0.0.1, 9.0.0.2
IBM Common Licensing ART 9.0, 9.0.0.1, 9.0.0.2
Web UI components exposed by the above versions

Discovery Timeline

2026-09-18 - CVE-2026-1029 published to the National Vulnerability Database (NVD)
2026-09-18 - Last updated in NVD database

Technical Details for CVE-2026-1029

Vulnerability Analysis

The vulnerability is a cross-site scripting flaw in the Web UI of IBM Common Licensing Agent and ART 9.0 releases. The application accepts user-supplied input and renders it into HTML responses without sufficient output encoding or input sanitization. An authenticated attacker with low privileges can submit a payload containing HTML or JavaScript. That payload is later returned to another user's browser, where it executes with the privileges of the viewing user. Because the scope is changed, the injected script runs in a security context beyond the attacker's own, permitting theft of session cookies, tokens, or credentials handled within the Web UI. The attack requires the victim to load the affected page, satisfying the user interaction requirement.

Root Cause

The root cause is improper neutralization of input during web page generation, classified as [CWE-79]. Untrusted user input reaches HTML sinks in the Web UI without contextual output encoding. The application also lacks a restrictive Content Security Policy (CSP) that would limit inline script execution.

Attack Vector

Exploitation occurs over the network against the licensing Web UI. The attacker must hold valid low-privilege credentials to submit content that will later be rendered to other users. When an administrator or peer user views the tainted view, the script executes in their browser session. No public proof-of-concept, exploit code, or in-the-wild exploitation has been reported for CVE-2026-1029. Refer to the IBM Support Page for vendor-supplied technical details.

Detection Methods for CVE-2026-1029

Indicators of Compromise

Web UI fields or stored records containing HTML tags such as <script>, <img onerror=, <svg onload=, or javascript: URIs.
Unexpected outbound HTTP requests from administrator browsers to attacker-controlled hosts shortly after viewing licensing pages.
Session cookies or authentication tokens appearing in web server access logs as query-string parameters.

Detection Strategies

Inspect HTTP request bodies to the Common Licensing Agent Web UI for script tags, event handlers, or encoded payloads such as %3Cscript%3E.
Review application logs for stored user input that includes markup characters <, >, ", or ' in fields not expected to accept HTML.
Correlate authenticated user sessions with anomalous DOM-manipulation activity or JavaScript errors reported by client browsers.

Monitoring Recommendations

Deploy a web application firewall (WAF) rule set that logs and alerts on XSS patterns targeting the licensing Web UI endpoints.
Enable and centrally collect browser Content Security Policy violation reports for administrative interfaces.
Monitor for privileged accounts whose sessions perform unexpected API calls immediately after loading licensing pages.

How to Mitigate CVE-2026-1029

Immediate Actions Required

Apply the fix documented on the IBM Support Page for Common Licensing Agent and ART 9.0.x.
Restrict network access to the licensing Web UI to trusted administrative networks only.
Rotate credentials and session tokens for accounts that may have interacted with untrusted content in the Web UI.
Audit stored records for previously injected HTML or JavaScript payloads and remove them.

Patch Information

IBM has released remediation guidance for CVE-2026-1029. Administrators should consult the IBM Support Page for the fixed release, interim fix identifiers, and installation instructions covering Agent 9.0, 9.0.0.1, 9.0.0.2 and ART 9.0, 9.0.0.1, 9.0.0.2.

Workarounds

Limit accounts with write access to fields rendered in the Web UI until the patch is deployed.
Enforce a strict Content Security Policy at the reverse proxy that disallows inline scripts and untrusted origins.
Require administrators to access the licensing Web UI from a dedicated, hardened browser profile.

bash

# Example reverse proxy header to reduce XSS impact
add_header Content-Security-Policy "default-src 'self'; script-src 'self'; object-src 'none'; frame-ancestors 'none'" always;
add_header X-Content-Type-Options "nosniff" always;
add_header X-Frame-Options "DENY" always;